RxPG News XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!  

Medical Research Health Special Topics World
 
  Home
 
 Careers 
 Dental
 Medical
 Nursing
 
 Latest Research 
 Aging
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Psychiatry
 Public Health
 Radiology
 Rheumatology
 Surgery
 Urology
 Alternative Medicine
 Medicine
 Epidemiology
 Sports Medicine
 Toxicology
 
 Medical News 
 Awards & Prizes
 Epidemics
 Health
 Healthcare
 Launch
 Opinion
 Professionals
 
 Special Topics 
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
 
 DocIndia 
 Reservation Issue
 Overseas Indian Doctor

Last Updated: May 20, 2007 - 10:48:48 AM
News Report
America Channel

subscribe to America newsletter
America

   EMAIL   |   PRINT
Cyclist Landis denies doping allegations
May 15, 2007 - 2:41:17 PM
Landis says he was offered a deal by USADA to get off with a light sentence if he provided doping evidence against former teammate - seven-time Tour de France winner Lance Armstrong.

Article options
 Email to a Friend
 Printer friendly version
 America channel RSS
 More America news
[RxPG] Washington, May 15 - American cyclist Floyd Landis has denied using performance-enhancing drugs at the start of his 10-day hearing before an arbitration panel in California.

Landis' lawyer Monday called the case brought by the US Anti-Doping Agency - an 'utter disaster' and disputed the credibility of a lab test conducted in Paris after his 2006 victory, which showed that he had taken testosterone, the Los Angeles Times reported.

The USADA's chief lawyer said in response that there was 'no natural explanation' for the large amounts of testosterone found in Landis' urine sample taken during the race. He added that follow-up tests by the USADA itself of seven more samples had only confirmed the result.

Apart from the loss of his Tour de France title, Landis faces a two-year suspension from the cycling tour if the three-member panel rules against him.

Tour de France's race director Christian Prudhomme told German newspaper Frankfurter Allgemeine Zeitung last week that Landis would be removed from the official list of tour winners regardless of the outcome of the US trial.

The case is the first ever public hearing by the USADA - something Landis himself insisted on after a ground-swell of support in the US - and is being held at Pepperdine University School of Law in Malibu, California.

Landis' case is one of many doping scandals to have rocked the cycling world in recent months. An investigation was recently reopened in Spain into a clinic that allegedly provided doping drugs to dozens of professional athletes.

Italian star racer Ivan Basso earlier this month admitted he was among those who used the banned practice of self-transfusion of blood at the clinic of Spanish doctor Eufemiano Fuentes.

Dozens of scientists are expected to testify before the panel in Landis' hearing, which the American cyclist has sought to turn into a trial on how doping tests are conducted and evaluated.

Landis says he was offered a deal by USADA to get off with a light sentence if he provided doping evidence against former teammate - seven-time Tour de France winner Lance Armstrong.

Armstrong has been accused of using performance-enhancing drugs by French newspapers, but never tested positive for doping.





Related America News
Run to support fight against kidney disease
Mexican footballer banned for life for doping
Ranbaxy gets FDA approval for allergy drug
Sunita Williams assembles special space walk tool
Simpson misses charity benefit
Chronic pain may impair your memory
Silicon Valley companies provide technology for latest 'Shrek' film
Israel threatens to take 'other military actions' in Gaza
'World bank can now refocus on poverty in South Asia'
Microsoft buys ad-firm Aquantive for $6 bn

Subscribe to America Newsletter
E-mail Address:

 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
© All rights reserved 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us